'Enhanced recovery after surgery' (ERAS) following Ivor-Lewis esophagectomy

Not Applicable

• Conditions: Esophageal carcinoma; C15; Malignant neoplasm of oesophagus

• Registration Number: DRKS00009513
• Lead Sponsor: niversitätsklinikum Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

•Patients with esophageal carcinoma with/without neoadjuvant therapy scheduled for Ivor-Lewis esophagectomy
•ASA I and II
•Preoperative weight loss < 10% of body weight
•BMI >18.5 and <30
•Respiratory function: FEV and VC >80%,
•Cardiovascular function: Stress ECG > 100 Watt, no history of MI
•Informed consent

Exclusion Criteria

•Chronic renal failure
•Insulin dependent diabetes mellitus

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of postoperative IIIB and IV complication (Clavien-Dindo score)

Secondary Outcome Measures

Name	Time	Method
Hospital stay (in days) and hospital costs (in Euro)